Nina Vene

638 total citations
26 papers, 476 citations indexed

About

Nina Vene is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Nina Vene has authored 26 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 9 papers in Internal Medicine and 5 papers in Surgery. Recurrent topics in Nina Vene's work include Atrial Fibrillation Management and Outcomes (14 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Cardiac Arrhythmias and Treatments (7 papers). Nina Vene is often cited by papers focused on Atrial Fibrillation Management and Outcomes (14 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Cardiac Arrhythmias and Treatments (7 papers). Nina Vene collaborates with scholars based in Slovenia, Sweden and Poland. Nina Vene's co-authors include Alenka Mavri, Katarina Košmelj, Mojca Božič Mijovski, Mojca Stegnar, Mojca Stegnar, Barbara Salobir, Irena Keber, Mišo Šabović, Miran Šebeštjen and Borut Jug and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Nina Vene

26 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nina Vene Slovenia 14 334 158 69 51 47 26 476
Nebojša Antonijević Serbia 11 191 0.6× 123 0.8× 145 2.1× 25 0.5× 68 1.4× 65 430
Miklós Rohla Austria 15 419 1.3× 100 0.6× 32 0.5× 38 0.7× 125 2.7× 54 605
Mika Skeppholm Sweden 15 584 1.7× 270 1.7× 101 1.5× 43 0.8× 72 1.5× 23 728
Ann-Kristin Öhlin Sweden 13 162 0.5× 157 1.0× 247 3.6× 36 0.7× 57 1.2× 22 500
Biagio De Simone Italy 7 292 0.9× 111 0.7× 34 0.5× 29 0.6× 87 1.9× 8 614
George A. Fritsma United States 10 106 0.3× 81 0.5× 152 2.2× 44 0.9× 47 1.0× 30 332
Jean Amiral France 10 104 0.3× 97 0.6× 131 1.9× 48 0.9× 55 1.2× 13 423
Brian Dale Australia 9 201 0.6× 165 1.0× 81 1.2× 17 0.3× 58 1.2× 17 396
Kagari Murasaki Japan 10 217 0.6× 80 0.5× 45 0.7× 43 0.8× 54 1.1× 19 296
Mariola Cieśla‐Dul Poland 8 108 0.3× 147 0.9× 131 1.9× 172 3.4× 76 1.6× 10 365

Countries citing papers authored by Nina Vene

Since Specialization
Citations

This map shows the geographic impact of Nina Vene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina Vene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina Vene more than expected).

Fields of papers citing papers by Nina Vene

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina Vene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina Vene. The network helps show where Nina Vene may publish in the future.

Co-authorship network of co-authors of Nina Vene

This figure shows the co-authorship network connecting the top 25 collaborators of Nina Vene. A scholar is included among the top collaborators of Nina Vene based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina Vene. Nina Vene is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mavri, Alenka, Nina Vene, Mojca Božič Mijovski, et al.. (2021). Apixaban concentration variability and relation to clinical outcomes in real-life patients with atrial fibrillation. Scientific Reports. 11(1). 13908–13908. 21 indexed citations
2.
Mijovski, Mojca Božič, Rickard E. Malmström, Nina Vene, Jovan P. Antović, & Alenka Mavri. (2021). The in vitro addition of idarucizumab to plasma samples from patients increases thrombin generation. Scientific Reports. 11(1). 5920–5920. 3 indexed citations
3.
Vene, Nina, et al.. (2020). Risk of major bleeding in elderly patients with atrial fibrillation on direct oral anticoagulants: real world experience. International Journal of Clinical Pharmacy. 42(2). 445–452. 7 indexed citations
4.
Vene, Nina, Alenka Mavri, Mojca Božič Mijovski, et al.. (2020). Idarucizumab for dabigatran reversal in daily clinical practice. European Journal of Anaesthesiology. 37(10). 874–878. 8 indexed citations
5.
Mavri, Alenka, Nina Vene, Mojca Božič Mijovski, et al.. (2019). Intra- and inter- individual rivaroxaban concentrations and potential bleeding risk in patients with atrial fibrillation. European Journal of Clinical Pharmacology. 75(8). 1069–1075. 34 indexed citations
6.
7.
Malmström, Rickard E., Nina Vene, Yuko Rönquist-Nii, et al.. (2015). Dabigatran Concentration: Variability and Potential Bleeding Prediction In “Real-Life” Patients With Atrial Fibrillation. Basic & Clinical Pharmacology & Toxicology. 117(5). 323–329. 34 indexed citations
8.
Vene, Nina, et al.. (2014). Unprovoked proximal venous thrombosis is associated with an increased risk of asymptomatic pulmonary embolism. Thrombosis Research. 133(6). 1011–1015. 15 indexed citations
9.
Vene, Nina, Barbara Salobir, Miran Šebeštjen, et al.. (2009). Prognostic impact of haemostatic derangements in chronic heart failure. Thrombosis and Haemostasis. 102(8). 314–320. 13 indexed citations
10.
Jug, Borut, Barbara Salobir, Nina Vene, et al.. (2009). Interleukin-6 is a stronger prognostic predictor than high-sensitive C-reactive protein in patients with chronic stable heart failure. Heart and Vessels. 24(4). 271–276. 37 indexed citations
11.
Vene, Nina. (2008). HORMONE REPLACEMENT THERAPY AND VENOUS THROMBOEMBOLISM. SHILAP Revista de lepidopterología. 77. 39–42. 3 indexed citations
12.
Mavri, Alenka, Katarina Košmelj, Mojca Stegnar, & Nina Vene. (2003). High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy. Thrombosis and Haemostasis. 90(12). 1163–1172. 86 indexed citations
13.
Stegnar, Mojca, Nina Vene, & Mojca Božič Mijovski. (2003). Do Haemostasis Activation Markers that Predict Cardiovascular Disease Exist?. Pathophysiology of Haemostasis and Thrombosis. 33(5-6). 302–308. 20 indexed citations
14.
Kaplan-Pavlovčič, Staša, Alenka Vizjak, Nina Vene, & D Ferluga. (1998). Antineutrophil cytoplasmic autoantibodies in atheroembolic disease. Nephrology Dialysis Transplantation. 13(4). 985–987. 10 indexed citations
15.
Stegnar, Mojca, Polona Peternel, D. Keber, & Nina Vene. (1991). Poor fibrinolytic response to venous occlusion by different criteria in patients with deep vein thrombosis. Thrombosis Research. 64(4). 445–453. 15 indexed citations
16.
Stegnar, Mojca, Borut Božič, Polona Peternel, et al.. (1991). Prevalence of antiphospholipid antibodies in deep vein thrombosis and their relationship to blood coagulation and fibrinolysis. Thrombosis Research. 63(4). 433–443. 29 indexed citations
17.
Stegnar, Mojca, Polona Peternel, & Nina Vene. (1990). Poor response to venous occlusion by different criteria in deep vein thrombosis. Fibrinolysis and Proteolysis. 4. 70–70. 1 indexed citations
18.
Peternel, Polona, et al.. (1990). Shift work and circadian rhythm of blood fibrinolytic parameters. Fibrinolysis and Proteolysis. 4. 113–115. 14 indexed citations
19.
Vene, Nina & Mojca Stegnar. (1990). Tissue-type plasminogen activator and plasminogen activator inhibitor-1 after exercise: comparison to venous occlusion and DDAVP. Fibrinolysis and Proteolysis. 4. 105–107. 4 indexed citations
20.
Keber, D., Mojca Stegnar, Nina Vene, Polona Peternel, & Irena Keber. (1986). Diurnal fluctuation of tissue plasminogen activator: Effects of recumbency and parenteral nutrition. Thrombosis Research. 41. 109–109. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nebojša Antonijević Breakdown of academic impact, for papers by Miklós Rohla Breakdown of academic impact, for papers by Mika Skeppholm Breakdown of academic impact, for papers by Ann-Kristin Öhlin Breakdown of academic impact, for papers by Biagio De Simone Breakdown of academic impact, for papers by George A. Fritsma Breakdown of academic impact, for papers by Jean Amiral Breakdown of academic impact, for papers by Brian Dale Breakdown of academic impact, for papers by Kagari Murasaki Breakdown of academic impact, for papers by Mariola Cieśla‐Dul
Rankless by CCL
2026